www.mimalaria.org/pamc/ConferenceInforma...abid/54/Default.aspx



Dr. Soriba Cisse, Chief Scientific Officer – Director

Dr. Cisse, Medical Degree – University of Abidjan, Ivory Coast, a neurobiologist trained at Universite de Montreal (PhD 1990) and McGill University (Post Doc 1992-1994), heads Millenia’s product development. Dr. Cisse has many personal achievements, including participating in IMAGE, an award winning team lead by Denis Gauvreau. IMAGE, is a multidisciplinary approach to the genetics and epidemiology of Alzheimer’s disease. His work led to fundamental discoveries in the aging human brain. He did research at the laboratory of Nobel Prize winner, James Watson, at Case Western in Cleveland with Alzheimer expert, George Perry and post-doc work in the dynamic Parkinson research team at the Jewish General Hospital (Lady Davis Institute) in Montreal. For eight years Dr. Cisse was scientific advisor to the AIDS program of FONDIS and a special advisor to the Minister of Health in Guniea Conakry. He held positions as Director of Quality Control and Vice-President R&D at BioMedco Canada, Inc., developing immunodiagnostic kits. Dr. Cisse has been involved with basic research throughout his professional career, has co-authored scientific papers and articles and has delivered lectures, at a number of symposiums.

www.freepatentsonline.com/20070032460.pdf

New Contract to Also Generate Further Sales Over 12 Months
MONTREAL, /PRNewswire-FirstCall/ -- Millenia Hope Inc., a Delaware Biopharma corporation (OTC Bulletin Board: MLHP - News; Berlin: MLF - News), today announced that it has sold 10,000 treatments of MMH Malarex(TM)/MMH 18(TM) to a private clinic in Mali. This sale is the initial order from a second contract that could also generate sales of 100,000 treatments over the next 12 months.
Previously, on August 10, 2005, Millenia Hope announced its initial African sale of 25,000 treatments from a contract totaling 100,000 treatments spread over the following 12 months. Leonard Stella, CEO, stated, "It is very satisfying to know that we are part of the solution to such an insidious and devastating problem, the malaria plague. Millenia pledges its very best effort to help in curing this killer disease.
"There are 300-500 million malaria-infected individuals globally; three (3) million die annually, of which 1 million are children under five (5) years of age. An effective malaria cure is urgently needed. In many regions, 70% or more of malaria strains are resistant to existing medications and the World Health Organization (WHO) is no longer funding products like chloroquine to which malaria is resistant. MMH Malarex(TM)/MMH 18(TM) cures malaria in those regions where resistant strains are prevalent. MMH Malarex(TM) has cured nearly 1,000 malaria sufferers in its various trials over the last five (5) years. We are saving lives right now!"
About Millenia Hope
Millenia hope is in the business of developing innovative treatments and quality medication products that will lead to healthier lives. Our people are committed to research and development to deliver on medical needs globally and to bring hope through healthcare solutions.
Safe Harbor Statement
Certain statements made in this release may contain language describing the plans, goals, strategies, intentions, forecasts and expectations of Millenia Hope that may be referred to as "forward-looking statements." Several important factors could cause actual results to differ materially from those in such forward-looking statements, and Millenia Hope could encounter unanticipated obstacles and delays in developing products, service offerings and markets.

For further information, please contact: Mr. Hugo Valente Tel: (514) 846-5757 or (514) 288-8822 Fax: (514) 935-9758 www.milleniahope.com

MLHP - Strong Buy $$$$&&&

GLTA - ALL IMO $$$$

Barchart USA:

Quelle:

Barchart.com - Opinion - MLHP MILLENIA HOPE INC OTC


MLHP - MILLENIA HOPE INC (OTC)

Date Open High Low Last Change Volume % Change
10/30/09 0.0016 0.0026 0.0010 0.0018 +0.0003 36077801 +20.00%


Composite Indicator
Trend Spotter TM Sell

Short Term Indicators
7 Day Average Directional Indicator Buy
10 - 8 Day Moving Average Hilo Channel Buy
20 Day Moving Average vs Price Buy
20 - 50 Day MACD Oscillator Hold
20 Day Bollinger Bands Buy

Short Term Indicators Average: 80% - Buy
20-Day Average Volume - 5689240

Medium Term Indicators
40 Day Commodity Channel Index Buy
50 Day Moving Average vs Price Buy
20 - 100 Day MACD Oscillator Buy
50 Day Parabolic Time/Price Buy

Medium Term Indicators Average: 100% - Buy
50-Day Average Volume - 3119434


Long Term Indicators
60 Day Commodity Channel Index Buy
100 Day Moving Average vs Price Buy
50 - 100 Day MACD Oscillator Buy

Long Term Indicators Average: 100% - Buy
100-Day Average Volume - 2252133

Overall Average: 80% - Buy

Price Support Pivot Point Resistance

0.0018 0.0002 0.0018 0.0034